Pons BE, Afonso LJA, Ruau AMC

Language: Spanish
References: 13
Page: 232-238
PDF size: 704.78 Kb.

ABSTRACT

The arterial hypertension control is the most effective measure to reach the decrease of the total mortality. A current proposal to reach this goal is the implementation of standardized treatment regimes, associated to the secondary prevention of the ischemic heart disease. In this sense it is important the access of the patient to the medicines, the team work and the surveillance of the arterial pressure control and the progress of the patients receiving treatment, for what monitoring and assessment are main elements.

REFERENCES

1. Patel P, Ordunez P, DiPette D, et al. for the Standardized Hypertension Treatment and Prevention Network. Improved Blood Pressure Control to Reduce Cardiovascular Disease Morbidity and Mortality: The Standardized Hypertension Treatment and Prevention Project. Rev Panam Salud Pública. 2017;41:1. Citado en PubMed; PMID: 28614461.

2. OPS. OMS. Enfermedades Transmisibles y Análisis de Salud/Información y Análisis de Salud: Situación de Salud en las Américas: Indicadores Básicos 2015. Washinton, D.C.: OMS; 2015.

3. World Health Organization. The world health report [Internet]. Washinton, D.C.: World Health Organization; 2010 [citado 12/12/2017]. Disponible en: http://apps.who.int/iris/bitstream/handle/10665/44371/9789241564021_eng.pdf;jses sionid=C163012C49D5C5943150BA59644C7C91?sequence=1

4. World Heart Federation Roadma. Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease. LOBAL HEART [Internet]. 2015 [citado 12/12/2017];10(2):99-11. Disponible en: http://www.cvdroadmaps.org/assets/downloads/The_World_Heart_Federation_Roadm ap_for_Secondary_Prevention_of_Cardiovascular_Disease.pdf

5. Perel P, Bianco E, Poulterz N, et al. Reducing Premature Cardiovascular Mortality By 2025 The World Heart Federation Roadmap. Glob Heart. 2015;10(2):97-8. Citado en PubMed; PMID: 26213296.

6. World Health Organization. Technical package for cardiovascular disease management in primary health care [Internet]. EE UU: World Health Organization; 2016 [citado 2/12/17]. Disponible en: https://www.who.int/cardiovascular_diseases/hearts/Hearts_package.pdf

7. Campbell N. Canadian Hypertension Education Program. Brief overview of 2004 recommendations. Can Fam Physician. 2004;50:1411-5. Citado en PubMed; PMID: 15526879.

8. Padwal R, Campbell N. Blood Pressure Control in Canada: Through the Looking- Glass Into a Glass Half Empty? Commentary. AJH Internet]. 2017 [citado 02/12/2017];30(3):223–5. Disponible en: https://academic.oup.com/ajh/article/30/3/223/2804

9. Jaffe MG, Young JD. The Kaiser Permanente Northern California Story: Improving Hypertension Control From 44% to 90% in 13 Years (2000 to 2013). J Clin Hypertens (Greenwich). 2016;18(4):260-1. Citado en PubMed; PMID: 26939059.

10. Pérez Caballero MD, León Álvarez JL, Dueñas Herrera A. Guía Cubana de Diagnóstico, Evaluación y Tratamiento de la HTA. Rev Cubana de medic [Internet]. 2017 [citado 02/12/2017];56(4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232017000400001

11. Pinnock H, Barwick M, Carpenter CR, et al. Standars for Reporting Implementation Studies (StaRI) statement. BMJ. 2017;356:i6795. Citado en PubMed; PMID: 28264797.

12. Campbell N, Ordunez P, Jaffe MG, et al. Implementing standardized performance indicators to improve hypertension control at both the population and healthcare organization levels. J Clin Hypertens (Greenwich). 2017;19(5):456-461. Citado en PubMed; PMID: 28191704.

13. Organización Panamericana de la Salud. Marco de monitoreo y evaluación para programas de control de Hipertensión [Internet]. Washington, D.C,: OPS; 2018 [citado 02/12/2017]. Disponible en: http://iris.paho.org/xmlui/bitstream/handle/123456789/34910/OPSNMH18001_spa.pd f?sequence=1&isAllowed=y